Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is defined by the absence of the estrogen receptor (ER), progesterone receptor (PR) and the lack of overexpression or gene amplification of the human epidermal growth factor receptor 2 (HER2)1. Here, ESR1 is linked to breast cancer.